Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc. (LIPO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
lipo · stock forecast · 0 analysts (3M) · FMP · updated Jun 4, 2026
Analyst Rating & Consensus
Based on 0 Wall Street analysts in the past 3 months
N/A
0 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$2.00
Consensus
$2.00
+1900.0% upside
Low
$2.00
Median: $2 · Last Close: $0.10
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.10 | ↑ 0.00% |
1-day model range: $0.1–$0.1. Peak: $0.1 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LIPO · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|
Wall Street analysts have recently issued updated ratings on Lipella Pharmaceuticals Inc. (LIPO) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 0 analysts currently cover LIPO.
Analyst Recommendation Trends
LIPO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↓ 8.1% YoY
Revenue Next Year
$1M
↑ 4.3% YoY
EPS This Year
$-5.20
EPS Next Year
$-17.42
↑ 235.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast LIPO EPS of $-5.20 for the current fiscal year, based on estimates from 1 analysts. The LIPO revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The LIPO stock forecast is supported by two independent data sources: analyst consensus ratings from 0 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LIPO price target is $2.00 (+1900.0% upside), with an analyst consensus of N/A.
The LIPO short-term stock prediction for tomorrow is $0.10 (+0.00%).
Lipella Pharmaceuticals Inc. trades on OTC under the ticker LIPO. The LIPO stock outlook for 2027 is broadly mixed, supported by a N/A consensus among 0% of covering analysts.
Frequently asked questions
LIPO forecast · 8 questionsAccording to 0 Wall Street analysts, the average 12-month LIPO price target is $2.00, with a high forecast of $2.00 and a low of $2.00. The median price target is shown in the chart above when available. This implies +1900.0% potential upside from the current price of $0.10.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.